世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

APAC受託製造市場 - 産業動向と2030年までの予測


APAC Contract Manufacturing Market - Industry Trends and Forecast to 2030

アジア太平洋地域の受託製造市場は、2023年から2030年の予測期間において5.8%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Data Bridge Market Research
データブリッジマーケットリサーチ
2023年1月3日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
247 英語

 

サマリー

アジア太平洋地域の受託製造市場は、2023年から2030年の予測期間において5.8%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、予測期間は2023年から2030年です
市場セグメンテーション
アジア太平洋地域の受託製造市場、製品別(医療機器製造、医薬品製造)、エンドユーザー別(相手先ブランド製造会社、医療機器会社、製薬会社、バイオテクノロジー会社、バイオ医薬品会社、研究機関)、流通チャネル(直接入札、小売販売、その他)、国(中国、日本、インド、韓国、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、その他アジア太平洋) 産業動向および2030年までの予測
アジア太平洋地域の受託製造市場の成長に寄与する主な要因としては、以下のようなものが挙げられます:
- ヘルスケア分野における技術的進歩の拡大
- 費用対効果の向上とキープレイヤーのグローバルなプレゼンス
市場のプレイヤー:

アジア太平洋地域の受託製造市場で活動している主なプレイヤーは以下の通りです:

- アエノバグループ
- サーモフィッシャーサイエンティフィック社(Thermo Fisher Scientific, Inc.
- エボニック・インダストリーズ・アグ
- ロンザ
- ベーリンガーインゲルハイムバイオファーマシューティカルズGmbH.
- キャタレント社
- サンファーマシューティカルインダストリー株式会社
- ニプロファーマ株式会社
- ファイザー株式会社(Pfizer Inc.
- レシファームAB
- ヴェター
- TEコネクティビティ
- メルクKGaA
- アルマックグループ
- ジークフリードホールディングAG
- ジュビラント・ファーマ・リミテッド
- アビッドバイオサービシーズ株式会社
- バクスター
- キンブルエレクトロニクス株式会社
- ファマーヘルスケアサービス
- アッヴィー社(AbbVie Inc.



ページTOPに戻る


目次

TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF THE ASIA PACIFIC CONTRACT MANUFACTURING MARKET 42
1.4 CURRENCY AND PRICING 44
1.5 LIMITATIONS 44
1.6 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 DBMR TRIPOD DATA VALIDATION MODEL 50
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT SEGMENT LIFELINE CURVE 54
2.8 MARKET END USER COVERAGE GRID 55
2.9 DBMR MARKET POSITION GRID 56
2.10 VENDOR SHARE ANALYSIS 57
2.11 SECONDARY SOURCES 58
2.12 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 PESTEL ANALYSIS 62
4.2 PORTER'S FIVE FORCES 63
4.3 STRATEGIC INITIATIVES: 64
5 REGULATORY FRAMEWORK 65
5.1 REGULATORY SCENARIO BY FDA 65
5.2 REGULATORY SCENARIO IN AUSTRALIA 66
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES 67
6 MARKET OVERVIEW 68
6.1 DRIVERS 70
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES 70
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING 70
6.1.3 ASIA PACIFIC PRESENCE AND CONNECTED NETWORK 71
6.2 RESTRAINTS 71
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS 71
6.2.2 RISK OF CONFIDENTIAL INFORMATION 72
6.3 OPPORTUNITIES 72
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS 72
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 73
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73
6.4 CHALLENGES 74
6.4.1 INTELLECTUAL PROPERTY RISKS 74
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES 74
7 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT 75
7.1 OVERVIEW 76
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING 79
7.2.1 TYPES OF PRODUCTS 80
7.2.1.1 TABLETS 80
7.2.1.2 CAPSULES 80
7.2.1.3 BIOLOGICS 81
7.2.1.4 SMALL MOLECULE 81
7.2.1.5 CELL & GENES MANUFACTURING 81
7.2.1.6 NUTRACEUTICALS 81
7.2.1.7 OTHERS 81
7.2.2 TYPE OF SERVICES 81
7.2.2.1 DRUG DEVELOPMENT SERVICES 82
7.2.2.2 TABLET MANUFACTURING SERVICES 82
7.2.2.3 BIOLOGICS API MANUFACTURING 82
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES 82
7.2.2.5 OTHERS 82
7.2.3 BY DOSAGE FORM 82
7.2.3.1 SOLID FORMULATIONS 83
7.2.3.2 LIQUID FORMULATIONS 83
7.2.3.2.1 INJECTABLE 83
7.2.3.2.2 SYRUPS 83
7.2.3.3 SEMI-SOLID FORMULATIONS 83
7.2.3.4 TOPICAL DRUG FORMULATIONS 83
7.2.3.5 OTHERS 83
7.3 MEDICAL DEVICE MANUFACTURING 84
7.3.1 TYPE OF DEVICES 85
7.3.1.1 SYRINGES AND NEEDLES 86
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS 86
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES 86
7.3.1.4 DISPOSABLES 86
7.3.1.5 IVD DEVICES 87
7.3.1.6 CARDIOVASCULAR DEVICES 87
7.3.1.7 DIABETES CARE DEVICES 87
7.3.1.8 GENERAL SURGERY DEVICES 87
7.3.1.9 ORTHOPEDIC DEVICES 87
7.3.1.10 RESPIRATORY DEVICES 87
7.3.1.11 OPHTHALMIC DEVICES 87
7.3.1.12 DENTAL DEVICES 87
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES 87
7.3.1.14 LABORATORY EQUIPMENT 87
7.3.2 TYPE OF SERVICES 88
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT 88
7.3.2.2 DEVICE ASSEMBLY 88
7.3.2.3 REGULATORY ASSISTANCE 88
7.3.2.4 PACKAGING & LABELLING 88
7.3.2.5 STERILIZATION SERVICES 89
7.3.2.6 TRAINING AND VALIDATION 89
7.3.2.7 QUALITY ASSURANCE 89
7.3.2.8 OTHERS 89
7.3.3 BY DEVICE CLASS 89
7.3.3.1 CLASS I MEDICAL DEVICES 90
7.3.3.2 CLASS IIA MEDICAL DEVICES 90
7.3.3.3 CLASS IIB MEDICAL DEVICES 90
7.3.3.4 CLASS III MEDICAL DEVICES 90
8 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER 91
8.1 OVERVIEW 92
8.2 PHARMACEUTICAL COMPANIES 95
8.3 BIOTECHNOLOGY COMPANIES 95
8.4 BIOPHARMA COMPANIES 96
8.5 MEDICAL DEVICES COMPANIES 97
8.6 ORIGINAL EQUIPMENT MANUFACTURER 97
8.7 RESEARCH INSTITUTES 98
9 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL 99
9.1 OVERVIEW 100
9.2 RETAIL SALES 103
9.3 DIRECT TENDER 104
9.4 OTHERS 105
10 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY REGION 106
10.1 ASIA PACIFIC 107
10.1.1 JAPAN 120
10.1.2 CHINA 128
10.1.3 SOUTH KOREA 136
10.1.4 INDIA 143
10.1.5 AUSTRALIA 151
10.1.6 SINGAPORE 159
10.1.7 THAILAND 167
10.1.8 MALAYSIA 175
10.1.9 INDONESIA 183
10.1.10 PHILIPPINES 191
10.1.11 REST OF ASIA-PACIFIC 199
11 ASIA PACIFIC CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE 200
11.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 200
12 SWOT ANALYSIS 201
13 COMPANY PROFILE 202
13.1 AENOVA GROUP 202
13.1.1 COMPANY SNAPSHOT 202
13.1.2 COMPANY SHARE ANALYSIS 202
13.1.3 PRODUCT PORTFOLIO 203
13.1.4 RECENT DEVELOPMENTS 203
13.2 THERMO FISHER SCIENTIFIC INC. 204
13.2.1 COMPANY SNAPSHOT 204
13.2.2 REVENUE ANALYSIS 205
13.2.3 COMPANY SHARE ANALYSIS 205
13.2.4 PRODUCT PORTFOLIO 206
13.2.5 RECENT DEVELOPMENTS 206
13.3 EVONIK INDUSTRIES AG 207
13.3.1 COMPANY SNAPSHOT 207
13.3.2 REVENUE ANALYSIS 207
13.3.3 COMPANY SHARE ANALYSIS 208
13.3.4 PRODUCT PORTFOLIO 208
13.3.5 RECENT DEVELOPMENTS 208
13.4 LONZA 209
13.4.1 COMPANY SNAPSHOT 209
13.4.2 REVENUE ANALYSIS 209
13.4.3 COMPANY SHARE ANALYSIS 210
13.4.4 PRODUCT PORTFOLIO 210
13.4.5 RECENT DEVELOPMENTS 211
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. 212
13.5.1 COMPANY SNAPSHOT 212
13.5.2 REVENUE ANALYSIS 212
13.5.3 COMPANY SHARE ANALYSIS 213
13.5.4 PRODUCT PORTFOLIO 213
13.5.5 RECENT DEVELOPMENTS 213
13.6 ABBVIE INC. 214
13.6.1 COMPANY SNAPSHOT 214
13.6.2 REVENUE ANALYSIS 214
13.6.3 PRODUCT PORTFOLIO 215
13.6.4 RECENT DEVELOPMENT 215
13.7 ALMAC GROUP 216
13.7.1 COMPANY SNAPSHOT 216
13.7.2 PRODUCT PORTFOLIO 216
13.7.3 RECENT DEVELOPMENTS 216
13.8 AVID BIOSERVICES, INC. 217
13.8.1 COMPANY SNAPSHOT 217
13.8.2 REVENUE ANALYSIS 217
13.8.3 PRODUCT PORTFOLIO 218
13.8.4 RECENT DEVELOPMENT 218
13.9 BAXTER 219
13.9.1 COMPANY SNAPSHOT 219
13.9.2 REVENUE ANALYSIS 219
13.9.3 PRODUCT PORTFOLIO 220
13.9.4 RECENT DEVELOPMENTS 221
13.10 CATALENT, INC 222
13.10.1 COMPANY SNAPSHOT 222
13.10.2 REVENUE ANALYSIS 222
13.10.3 PRODUCT PORTFOLIO 223
13.10.4 RECENT DEVELOPMENT 223
13.11 FAMAR HEALTH CARE SERVICES 224
13.11.1 COMPANY SNAPSHOT 224
13.11.2 PRODUCT PORTFOLIO 224
13.11.3 RECENT DEVELOPMENTS 224
13.12 JUBILANT PHARMA LIMITED 225
13.12.1 COMPANY SNAPSHOT 225
13.12.2 REVENUE ANALYSIS 225
13.12.3 PRODUCT PORTFOLIO 226
13.12.4 RECENT DEVELOPMENT 226
13.13 KIMBALL INTERNATIONAL 227
13.13.1 COMPANY SNAPSHOT 227
13.13.2 REVENUE ANALYSIS 227
13.13.3 PRODUCT PORTFOLIO 228
13.13.4 RECENT DEVELOPMENT 228
13.14 MERCK KGAA 229
13.14.1 COMPANY SNAPSHOT 229
13.14.2 REVENUE ANALYSIS 229
13.14.3 PRODUCT PORTFOLIO 230
13.14.4 RECENT DEVELOPMENTS 230
13.15 NIPR0 231
13.15.1 COMPANY SNAPSHOT 231
13.15.2 REVENUE ANALYSIS 231
13.15.3 PRODUCT PORTFOLIO 232
13.15.4 RECENT DEVELOPMENT 232
13.16 PFIZER INC 233
13.16.1 COMPANY SNAPSHOT 233
13.16.2 REVENUE ANALYSIS 233
13.16.3 PRODUCT PORTFOLIO 234
13.16.4 RECENT DEVELOPMENT 234
13.17 RECIPHARM AB. 235
13.17.1 COMPANY SNAPSHOT 235
13.17.2 REVENUE ANALYSIS 235
13.17.3 PRODUCT PORTFOLIO 236
13.17.4 RECENT DEVELOPMENT 236
13.18 SIEGFRIED HOLDING AG 237
13.18.1 COMPANY SNAPSHOT 237
13.18.2 REVENUE ANALYSIS 237
13.18.3 PRODUCT PORTFOLIO 238
13.18.4 RECENT DEVELOPMENTS 238
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD 239
13.19.1 COMPANY SNAPSHOT 239
13.19.2 REVENUE ANALYSIS 239
13.19.3 PRODUCT PORTFOLIO 240
13.19.4 RECENT DEVELOPMENT 240
13.20 TE CONNECTIVITY 241
13.20.1 COMPANY SNAPSHOT 241
13.20.2 REVENUE ANALYSIS 241
13.20.3 PRODUCT PORTFOLIO 242
13.20.4 RECENT DEVELOPMENT 242
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG 243
13.21.1 COMPANY SNAPSHOT 243
13.21.2 PRODUCT PORTFOLIO 243
13.21.3 RECENT DEVELOPMENTS 243
14 QUESTIONNAIRE 244
15 RELATED REPORTS 247

ページTOPに戻る



図表リスト

LIST OF TABLES
TABLE 1 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59
TABLE 2 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 60
TABLE 3 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 4 ASIA PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 5 ASIA PACIFIC BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 62
TABLE 6 ASIA PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 63
TABLE 7 ASIA PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 64
TABLE 8 ASIA PACIFIC MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 9 ASIA PACIFIC CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 66
TABLE 10 ASIA PACIFIC TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 67
TABLE 11 ASIA PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 69
TABLE 12 ASIA PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 70
TABLE 13 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 75
TABLE 14 ASIA PACIFIC PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 15 ASIA PACIFIC BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 16 ASIA PACIFIC BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 17 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 18 ASIA PACIFIC ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 19 ASIA PACIFIC RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 20 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 83
TABLE 21 ASIA PACIFIC RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 22 ASIA PACIFIC DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 23 ASIA PACIFIC OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 24 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 92
TABLE 25 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92
TABLE 26 ASIA-PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 27 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 28 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT) 94
TABLE 29 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP) 94
TABLE 30 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 31 ASIA-PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 32 ASIA-PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 33 ASIA-PACIFIC MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96
TABLE 34 ASIA-PACIFIC TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96
TABLE 35 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 97
TABLE 36 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 98
TABLE 37 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 38 ASIA-PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 39 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 100
TABLE 40 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 100
TABLE 41 JAPAN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 42 JAPAN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 43 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 44 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 102
TABLE 45 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 102
TABLE 46 JAPAN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 47 JAPAN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 48 JAPAN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 49 JAPAN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
TABLE 50 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
TABLE 51 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 105
TABLE 52 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 106
TABLE 53 JAPAN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 54 JAPAN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 55 JAPAN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 108
TABLE 56 JAPAN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 108
TABLE 57 CHINA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 58 CHINA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 59 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 60 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 110
TABLE 61 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 110
TABLE 62 CHINA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 63 CHINA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 64 CHINA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 65 CHINA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
TABLE 66 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
TABLE 67 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 113
TABLE 68 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 114
TABLE 69 CHINA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 70 CHINA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 71 CHINA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 116
TABLE 72 CHINA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 116
TABLE 73 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 74 SOUTH KOREA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 75 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 76 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 118
TABLE 77 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 118
TABLE 78 SOUTH KOREA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 79 SOUTH KOREA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 80 SOUTH KOREA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 81 SOUTH KOREA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 82 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 83 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 121
TABLE 84 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 122
TABLE 85 SOUTH KOREA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 122
TABLE 86 SOUTH KOREA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 87 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 123
TABLE 88 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 123
TABLE 89 INDIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 90 INDIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 91 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 92 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 125
TABLE 93 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 125
TABLE 94 INDIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 95 INDIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 96 INDIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 97 INDIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 98 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 99 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 128
TABLE 100 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 129
TABLE 101 INDIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130
TABLE 102 INDIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130
TABLE 103 INDIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 131
TABLE 104 INDIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131
TABLE 105 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 106 AUSTRALIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 107 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 108 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 133
TABLE 109 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 133
TABLE 110 AUSTRALIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 111 AUSTRALIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 112 AUSTRALIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 113 AUSTRALIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 114 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 115 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 136
TABLE 116 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 137
TABLE 117 AUSTRALIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138
TABLE 118 AUSTRALIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138
TABLE 119 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 139
TABLE 120 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139
TABLE 121 SINGAPORE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140
TABLE 122 SINGAPORE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140
TABLE 123 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140
TABLE 124 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 141
TABLE 125 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 141
TABLE 126 SINGAPORE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142
TABLE 127 SINGAPORE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142
TABLE 128 SINGAPORE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142
TABLE 129 SINGAPORE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 130 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 131 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 144
TABLE 132 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 145
TABLE 133 SINGAPORE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146
TABLE 134 SINGAPORE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146
TABLE 135 SINGAPORE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 147
TABLE 136 SINGAPORE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 137 THAILAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
TABLE 138 THAILAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
TABLE 139 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
TABLE 140 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 149
TABLE 141 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 149
TABLE 142 THAILAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150
TABLE 143 THAILAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150
TABLE 144 THAILAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150
TABLE 145 THAILAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 146 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 147 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 152
TABLE 148 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 153
TABLE 149 THAILAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154
TABLE 150 THAILAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154
TABLE 151 THAILAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 155
TABLE 152 THAILAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 155
TABLE 153 MALAYSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
TABLE 154 MALAYSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
TABLE 155 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
TABLE 156 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 157
TABLE 157 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 157
TABLE 158 MALAYSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
TABLE 159 MALAYSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
TABLE 160 MALAYSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
TABLE 161 MALAYSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 162 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 163 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 160
TABLE 164 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 161
TABLE 165 MALAYSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 166 MALAYSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 167 MALAYSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 163
TABLE 168 MALAYSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 163
TABLE 169 INDONESIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 170 INDONESIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 171 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 172 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 165
TABLE 173 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 165

 

ページTOPに戻る


 

Summary

The Asia-Pacific contract manufacturing market is projected to register a substantial CAGR of 5.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030
Market Segmentation:
Asia-Pacific Contract Manufacturing Market, By Product (Medical Devices Manufacturing, Pharmaceutical Products Manufacturing), End User (Original Equipment Manufacturer, Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies, Biopharma Companies, Research Institutes), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Asia-Pacific contract manufacturing market are:
• Growing technological advancements in the healthcare sector
• Increased cost-effectiveness and global presence of key players
Market Players:

Some of the major players operating in the Asia-Pacific contract manufacturing market are:

• Aenova Group
• Thermo Fisher Scientific, Inc.
• EVONIK INDUSTRIES AG
• Lonza
• Boehringer Ingelheim Biopharmaceuticals GmbH.
• Catalent, Inc
• Sun Pharmaceutical Industries Ltd.
• NIPRO PHARMA CORPORATION
• Pfizer Inc.
• Recipharm AB.
• Vetter
• TE Connectivity
• Merck KGaA
• Almac Group
• Siegfried Holding AG
• Jubilant Pharma Limited
• Avid Bioservices, Inc.
• Baxter
• KIMBALL ELECTRONICS INC
• FAMAR Health Care Services
• AbbVie Inc.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF THE ASIA PACIFIC CONTRACT MANUFACTURING MARKET 42
1.4 CURRENCY AND PRICING 44
1.5 LIMITATIONS 44
1.6 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 DBMR TRIPOD DATA VALIDATION MODEL 50
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT SEGMENT LIFELINE CURVE 54
2.8 MARKET END USER COVERAGE GRID 55
2.9 DBMR MARKET POSITION GRID 56
2.10 VENDOR SHARE ANALYSIS 57
2.11 SECONDARY SOURCES 58
2.12 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 PESTEL ANALYSIS 62
4.2 PORTER'S FIVE FORCES 63
4.3 STRATEGIC INITIATIVES: 64
5 REGULATORY FRAMEWORK 65
5.1 REGULATORY SCENARIO BY FDA 65
5.2 REGULATORY SCENARIO IN AUSTRALIA 66
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES 67
6 MARKET OVERVIEW 68
6.1 DRIVERS 70
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES 70
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING 70
6.1.3 ASIA PACIFIC PRESENCE AND CONNECTED NETWORK 71
6.2 RESTRAINTS 71
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS 71
6.2.2 RISK OF CONFIDENTIAL INFORMATION 72
6.3 OPPORTUNITIES 72
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS 72
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 73
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73
6.4 CHALLENGES 74
6.4.1 INTELLECTUAL PROPERTY RISKS 74
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES 74
7 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT 75
7.1 OVERVIEW 76
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING 79
7.2.1 TYPES OF PRODUCTS 80
7.2.1.1 TABLETS 80
7.2.1.2 CAPSULES 80
7.2.1.3 BIOLOGICS 81
7.2.1.4 SMALL MOLECULE 81
7.2.1.5 CELL & GENES MANUFACTURING 81
7.2.1.6 NUTRACEUTICALS 81
7.2.1.7 OTHERS 81
7.2.2 TYPE OF SERVICES 81
7.2.2.1 DRUG DEVELOPMENT SERVICES 82
7.2.2.2 TABLET MANUFACTURING SERVICES 82
7.2.2.3 BIOLOGICS API MANUFACTURING 82
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES 82
7.2.2.5 OTHERS 82
7.2.3 BY DOSAGE FORM 82
7.2.3.1 SOLID FORMULATIONS 83
7.2.3.2 LIQUID FORMULATIONS 83
7.2.3.2.1 INJECTABLE 83
7.2.3.2.2 SYRUPS 83
7.2.3.3 SEMI-SOLID FORMULATIONS 83
7.2.3.4 TOPICAL DRUG FORMULATIONS 83
7.2.3.5 OTHERS 83
7.3 MEDICAL DEVICE MANUFACTURING 84
7.3.1 TYPE OF DEVICES 85
7.3.1.1 SYRINGES AND NEEDLES 86
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS 86
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES 86
7.3.1.4 DISPOSABLES 86
7.3.1.5 IVD DEVICES 87
7.3.1.6 CARDIOVASCULAR DEVICES 87
7.3.1.7 DIABETES CARE DEVICES 87
7.3.1.8 GENERAL SURGERY DEVICES 87
7.3.1.9 ORTHOPEDIC DEVICES 87
7.3.1.10 RESPIRATORY DEVICES 87
7.3.1.11 OPHTHALMIC DEVICES 87
7.3.1.12 DENTAL DEVICES 87
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES 87
7.3.1.14 LABORATORY EQUIPMENT 87
7.3.2 TYPE OF SERVICES 88
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT 88
7.3.2.2 DEVICE ASSEMBLY 88
7.3.2.3 REGULATORY ASSISTANCE 88
7.3.2.4 PACKAGING & LABELLING 88
7.3.2.5 STERILIZATION SERVICES 89
7.3.2.6 TRAINING AND VALIDATION 89
7.3.2.7 QUALITY ASSURANCE 89
7.3.2.8 OTHERS 89
7.3.3 BY DEVICE CLASS 89
7.3.3.1 CLASS I MEDICAL DEVICES 90
7.3.3.2 CLASS IIA MEDICAL DEVICES 90
7.3.3.3 CLASS IIB MEDICAL DEVICES 90
7.3.3.4 CLASS III MEDICAL DEVICES 90
8 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER 91
8.1 OVERVIEW 92
8.2 PHARMACEUTICAL COMPANIES 95
8.3 BIOTECHNOLOGY COMPANIES 95
8.4 BIOPHARMA COMPANIES 96
8.5 MEDICAL DEVICES COMPANIES 97
8.6 ORIGINAL EQUIPMENT MANUFACTURER 97
8.7 RESEARCH INSTITUTES 98
9 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL 99
9.1 OVERVIEW 100
9.2 RETAIL SALES 103
9.3 DIRECT TENDER 104
9.4 OTHERS 105
10 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY REGION 106
10.1 ASIA PACIFIC 107
10.1.1 JAPAN 120
10.1.2 CHINA 128
10.1.3 SOUTH KOREA 136
10.1.4 INDIA 143
10.1.5 AUSTRALIA 151
10.1.6 SINGAPORE 159
10.1.7 THAILAND 167
10.1.8 MALAYSIA 175
10.1.9 INDONESIA 183
10.1.10 PHILIPPINES 191
10.1.11 REST OF ASIA-PACIFIC 199
11 ASIA PACIFIC CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE 200
11.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 200
12 SWOT ANALYSIS 201
13 COMPANY PROFILE 202
13.1 AENOVA GROUP 202
13.1.1 COMPANY SNAPSHOT 202
13.1.2 COMPANY SHARE ANALYSIS 202
13.1.3 PRODUCT PORTFOLIO 203
13.1.4 RECENT DEVELOPMENTS 203
13.2 THERMO FISHER SCIENTIFIC INC. 204
13.2.1 COMPANY SNAPSHOT 204
13.2.2 REVENUE ANALYSIS 205
13.2.3 COMPANY SHARE ANALYSIS 205
13.2.4 PRODUCT PORTFOLIO 206
13.2.5 RECENT DEVELOPMENTS 206
13.3 EVONIK INDUSTRIES AG 207
13.3.1 COMPANY SNAPSHOT 207
13.3.2 REVENUE ANALYSIS 207
13.3.3 COMPANY SHARE ANALYSIS 208
13.3.4 PRODUCT PORTFOLIO 208
13.3.5 RECENT DEVELOPMENTS 208
13.4 LONZA 209
13.4.1 COMPANY SNAPSHOT 209
13.4.2 REVENUE ANALYSIS 209
13.4.3 COMPANY SHARE ANALYSIS 210
13.4.4 PRODUCT PORTFOLIO 210
13.4.5 RECENT DEVELOPMENTS 211
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. 212
13.5.1 COMPANY SNAPSHOT 212
13.5.2 REVENUE ANALYSIS 212
13.5.3 COMPANY SHARE ANALYSIS 213
13.5.4 PRODUCT PORTFOLIO 213
13.5.5 RECENT DEVELOPMENTS 213
13.6 ABBVIE INC. 214
13.6.1 COMPANY SNAPSHOT 214
13.6.2 REVENUE ANALYSIS 214
13.6.3 PRODUCT PORTFOLIO 215
13.6.4 RECENT DEVELOPMENT 215
13.7 ALMAC GROUP 216
13.7.1 COMPANY SNAPSHOT 216
13.7.2 PRODUCT PORTFOLIO 216
13.7.3 RECENT DEVELOPMENTS 216
13.8 AVID BIOSERVICES, INC. 217
13.8.1 COMPANY SNAPSHOT 217
13.8.2 REVENUE ANALYSIS 217
13.8.3 PRODUCT PORTFOLIO 218
13.8.4 RECENT DEVELOPMENT 218
13.9 BAXTER 219
13.9.1 COMPANY SNAPSHOT 219
13.9.2 REVENUE ANALYSIS 219
13.9.3 PRODUCT PORTFOLIO 220
13.9.4 RECENT DEVELOPMENTS 221
13.10 CATALENT, INC 222
13.10.1 COMPANY SNAPSHOT 222
13.10.2 REVENUE ANALYSIS 222
13.10.3 PRODUCT PORTFOLIO 223
13.10.4 RECENT DEVELOPMENT 223
13.11 FAMAR HEALTH CARE SERVICES 224
13.11.1 COMPANY SNAPSHOT 224
13.11.2 PRODUCT PORTFOLIO 224
13.11.3 RECENT DEVELOPMENTS 224
13.12 JUBILANT PHARMA LIMITED 225
13.12.1 COMPANY SNAPSHOT 225
13.12.2 REVENUE ANALYSIS 225
13.12.3 PRODUCT PORTFOLIO 226
13.12.4 RECENT DEVELOPMENT 226
13.13 KIMBALL INTERNATIONAL 227
13.13.1 COMPANY SNAPSHOT 227
13.13.2 REVENUE ANALYSIS 227
13.13.3 PRODUCT PORTFOLIO 228
13.13.4 RECENT DEVELOPMENT 228
13.14 MERCK KGAA 229
13.14.1 COMPANY SNAPSHOT 229
13.14.2 REVENUE ANALYSIS 229
13.14.3 PRODUCT PORTFOLIO 230
13.14.4 RECENT DEVELOPMENTS 230
13.15 NIPR0 231
13.15.1 COMPANY SNAPSHOT 231
13.15.2 REVENUE ANALYSIS 231
13.15.3 PRODUCT PORTFOLIO 232
13.15.4 RECENT DEVELOPMENT 232
13.16 PFIZER INC 233
13.16.1 COMPANY SNAPSHOT 233
13.16.2 REVENUE ANALYSIS 233
13.16.3 PRODUCT PORTFOLIO 234
13.16.4 RECENT DEVELOPMENT 234
13.17 RECIPHARM AB. 235
13.17.1 COMPANY SNAPSHOT 235
13.17.2 REVENUE ANALYSIS 235
13.17.3 PRODUCT PORTFOLIO 236
13.17.4 RECENT DEVELOPMENT 236
13.18 SIEGFRIED HOLDING AG 237
13.18.1 COMPANY SNAPSHOT 237
13.18.2 REVENUE ANALYSIS 237
13.18.3 PRODUCT PORTFOLIO 238
13.18.4 RECENT DEVELOPMENTS 238
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD 239
13.19.1 COMPANY SNAPSHOT 239
13.19.2 REVENUE ANALYSIS 239
13.19.3 PRODUCT PORTFOLIO 240
13.19.4 RECENT DEVELOPMENT 240
13.20 TE CONNECTIVITY 241
13.20.1 COMPANY SNAPSHOT 241
13.20.2 REVENUE ANALYSIS 241
13.20.3 PRODUCT PORTFOLIO 242
13.20.4 RECENT DEVELOPMENT 242
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG 243
13.21.1 COMPANY SNAPSHOT 243
13.21.2 PRODUCT PORTFOLIO 243
13.21.3 RECENT DEVELOPMENTS 243
14 QUESTIONNAIRE 244
15 RELATED REPORTS 247

ページTOPに戻る



List of Tables/Graphs

LIST OF TABLES
TABLE 1 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59
TABLE 2 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 60
TABLE 3 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 4 ASIA PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 5 ASIA PACIFIC BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 62
TABLE 6 ASIA PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 63
TABLE 7 ASIA PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 64
TABLE 8 ASIA PACIFIC MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 9 ASIA PACIFIC CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 66
TABLE 10 ASIA PACIFIC TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 67
TABLE 11 ASIA PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 69
TABLE 12 ASIA PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 70
TABLE 13 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 75
TABLE 14 ASIA PACIFIC PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 15 ASIA PACIFIC BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 16 ASIA PACIFIC BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 17 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 18 ASIA PACIFIC ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 19 ASIA PACIFIC RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 20 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 83
TABLE 21 ASIA PACIFIC RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 22 ASIA PACIFIC DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 23 ASIA PACIFIC OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 24 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 92
TABLE 25 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92
TABLE 26 ASIA-PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 27 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 28 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT) 94
TABLE 29 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP) 94
TABLE 30 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 31 ASIA-PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 32 ASIA-PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95
TABLE 33 ASIA-PACIFIC MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96
TABLE 34 ASIA-PACIFIC TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96
TABLE 35 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 97
TABLE 36 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 98
TABLE 37 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 38 ASIA-PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 39 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 100
TABLE 40 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 100
TABLE 41 JAPAN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 42 JAPAN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 43 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 44 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 102
TABLE 45 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 102
TABLE 46 JAPAN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 47 JAPAN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 48 JAPAN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
TABLE 49 JAPAN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
TABLE 50 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
TABLE 51 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 105
TABLE 52 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 106
TABLE 53 JAPAN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 54 JAPAN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 55 JAPAN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 108
TABLE 56 JAPAN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 108
TABLE 57 CHINA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 58 CHINA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 59 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 60 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 110
TABLE 61 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 110
TABLE 62 CHINA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 63 CHINA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 64 CHINA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111
TABLE 65 CHINA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
TABLE 66 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
TABLE 67 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 113
TABLE 68 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 114
TABLE 69 CHINA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 70 CHINA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 71 CHINA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 116
TABLE 72 CHINA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 116
TABLE 73 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 74 SOUTH KOREA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 75 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 76 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 118
TABLE 77 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 118
TABLE 78 SOUTH KOREA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 79 SOUTH KOREA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 80 SOUTH KOREA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 81 SOUTH KOREA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 82 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 83 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 121
TABLE 84 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 122
TABLE 85 SOUTH KOREA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 122
TABLE 86 SOUTH KOREA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 87 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 123
TABLE 88 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 123
TABLE 89 INDIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 90 INDIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 91 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 92 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 125
TABLE 93 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 125
TABLE 94 INDIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 95 INDIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 96 INDIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 97 INDIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 98 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127
TABLE 99 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 128
TABLE 100 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 129
TABLE 101 INDIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130
TABLE 102 INDIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130
TABLE 103 INDIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 131
TABLE 104 INDIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131
TABLE 105 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 106 AUSTRALIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 107 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 108 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 133
TABLE 109 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 133
TABLE 110 AUSTRALIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 111 AUSTRALIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 112 AUSTRALIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 113 AUSTRALIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 114 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 115 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 136
TABLE 116 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 137
TABLE 117 AUSTRALIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138
TABLE 118 AUSTRALIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138
TABLE 119 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 139
TABLE 120 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139
TABLE 121 SINGAPORE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140
TABLE 122 SINGAPORE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140
TABLE 123 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140
TABLE 124 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 141
TABLE 125 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 141
TABLE 126 SINGAPORE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142
TABLE 127 SINGAPORE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142
TABLE 128 SINGAPORE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142
TABLE 129 SINGAPORE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 130 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143
TABLE 131 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 144
TABLE 132 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 145
TABLE 133 SINGAPORE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146
TABLE 134 SINGAPORE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146
TABLE 135 SINGAPORE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 147
TABLE 136 SINGAPORE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 137 THAILAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
TABLE 138 THAILAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
TABLE 139 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
TABLE 140 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 149
TABLE 141 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 149
TABLE 142 THAILAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150
TABLE 143 THAILAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150
TABLE 144 THAILAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150
TABLE 145 THAILAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 146 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151
TABLE 147 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 152
TABLE 148 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 153
TABLE 149 THAILAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154
TABLE 150 THAILAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154
TABLE 151 THAILAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 155
TABLE 152 THAILAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 155
TABLE 153 MALAYSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
TABLE 154 MALAYSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
TABLE 155 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
TABLE 156 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 157
TABLE 157 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 157
TABLE 158 MALAYSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
TABLE 159 MALAYSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
TABLE 160 MALAYSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
TABLE 161 MALAYSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 162 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159
TABLE 163 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 160
TABLE 164 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 161
TABLE 165 MALAYSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 166 MALAYSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162
TABLE 167 MALAYSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 163
TABLE 168 MALAYSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 163
TABLE 169 INDONESIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 170 INDONESIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 171 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
TABLE 172 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 165
TABLE 173 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 165

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(apac)の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る